Transient bullous dermolysis of the newborn: genes and variants
Explore variant evidence for Transient bullous dermolysis of the newborn across 1 analyzed protein (COL7A1). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 8 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Transient bullous dermolysis of the newborn
COL7A1: Collagen alpha-1(VII) chain
It forms anchoring fibrils that secure the epidermal basement membrane to the underlying dermis. Pathogenic variants cause dystrophic epidermolysis bullosa, with skin fragility and scarring ranging from localized disease to severe generalized forms with major complications.
10 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in COL7A1 have source records linked to Transient bullous dermolysis of the newborn. Association strength is not clinical gene validity.
Where Transient bullous dermolysis of the newborn variants cluster
- COL7A1 Triple-helical region (positions 1254–2784): 10 of 10 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Transient bullous dermolysis of the newborn
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL7A1 G2674R | 2674 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 R2008H | 2008 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1569R | 1569 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 R2008G | 2008 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL7A1 R2424W | 2424 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2737R | 2737 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 R2580C | 2580 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2012V | 2012 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2213E | 2213 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 R2063G | 2063 | Triple-helical region | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Transient bullous dermolysis of the newborn
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- SIFT: 88 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 85 out of 100
Same protein, different disease
- Dystrophic epidermolysis bullosa also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Transient bullous dermolysis of the newborn variants (64 pathogenic / likely pathogenic).
- Recessive dystrophic epidermolysis bullosa also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Transient bullous dermolysis of the newborn variants (53 pathogenic / likely pathogenic).
- Generalized dominant dystrophic epidermolysis bullosa also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Transient bullous dermolysis of the newborn variants (26 pathogenic / likely pathogenic).
- Nonsyndromic congenital nail disorder 8 also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Transient bullous dermolysis of the newborn variants (15 pathogenic / likely pathogenic).
- Dominant dystrophic epidermolysis bullosa with absence of skin also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Transient bullous dermolysis of the newborn variants (12 pathogenic / likely pathogenic).
Diseases related to Transient bullous dermolysis of the newborn
- Dystrophic epidermolysis bullosa, also linked to COL7A1
- Recessive dystrophic epidermolysis bullosa, also linked to COL7A1
- Generalized dominant dystrophic epidermolysis bullosa, also linked to COL7A1
- Nonsyndromic congenital nail disorder 8, also linked to COL7A1
- Dominant dystrophic epidermolysis bullosa with absence of skin, also linked to COL7A1
- Epidermolysis bullosa simplex, dowling-meara, also linked to COL7A1
- Pretibial dystrophic epidermolysis bullosa, also linked to COL7A1
- Epidermolysis bullosa pruriginosa, also linked to COL7A1
- Epidermolysis bullosa, also linked to COL7A1
Frequently asked questions
Which genes have records linked to Transient bullous dermolysis of the newborn?
This view contains 1 analyzed proteins: COL7A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 8 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 37 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center